Skip to main content
Not sure where to start? Get matched →
All answers

Anti-Aging · Reference

Can You Take Ipamorelin With Tirzepatide or Semaglutide?

This page covers what each medication is, why they are paired, the three opposing effects, what the evidence shows, how the schedules fit, and how to add ipamorelin properly. Everything here applies to semaglutide the same way.

Ipamorelin (Injectable)
Ipamorelin$239/mo

Ipamorelin is sometimes prescribed alongside tirzepatide or semaglutide, usually with lean tissue in mind, but no study has tested the combination and no trial shows a growth hormone secretagogue preserves muscle during GLP-1 treatment. The two act on different receptors that pull in opposite directions in three places: ipamorelin acts at the receptor ghrelin uses to signal hunger, so some people notice more appetite; in rats it sped gastric emptying, where a GLP-1 slows it; and growth hormone reduces insulin sensitivity, where GLP-1 medications act the other way. None of that rules the pairing out. It is why glucose and appetite are part of the conversation with your physician.

This page covers what each medication is, why they are paired, the three opposing effects, what the evidence shows, how the schedules fit, and how to add ipamorelin properly. Everything here applies to semaglutide the same way.

Can You Take Ipamorelin With Tirzepatide or Semaglutide?

The short answer

Question Answer
Can they be prescribed together? Yes, and growth-hormone-axis peptides are among the common pairings with a GLP-1
Has the combination been studied? No
Why is it paired? Lean tissue, as an adjunct to training and protein
Does it add weight loss? No trial shows that; in mice ipamorelin increased body weight, fat and food intake
What pulls in opposite directions? Appetite, gastric emptying in animal work, and glucose
What gets watched? Glucose, and how your appetite responds
Same answer for semaglutide? Yes

The medications this page covers:

Product What is in it Typical directions Price
Ipamorelin 5 mL vial, ipamorelin 1 mg/mL (5 mg per vial) 0.25 mL (25 units) under the skin Monday through Friday nights at bedtime $239/mo
Tirzepatide Dose-specific 2 mL vials at six strengths, 2.5 mg to 15 mg weekly; glycine in the 2.5 mg and 7.5 mg vials 0.50 mL (50 units) once weekly at every strength From $159/mo
Semaglutide Dose-specific vials at six strengths, starting with 1 mg per 1 mL at the 0.25 mg starting dose Printed on the vial for your strength From $99/mo

Prices are all-in, covering medication, physician review, refill management and shipping, with no membership fee. GLP-1 prices are "from" prices, set by dose. Compounded medications are not FDA approved.

Can You Take Ipamorelin With Tirzepatide or Semaglutide?

Two signals from opposite ends of appetite

  • Tirzepatide

    Tirzepatide is a single peptide that activates the GIP and GLP-1 receptors. It acts on appetite centres in the brain, slows gastric emptying and changes insulin and glucagon signalling. See what is tirzepatide.

  • Ipamorelin

    Ipamorelin is a synthetic five-amino-acid peptide that imitates ghrelin, the stomach hormone that signals hunger and tells the pituitary to release growth hormone. It binds the ghrelin receptor, GHS-R1a, and produces a pulse of the body's own growth hormone; in the human volunteer study the pulse peaked at about 40 minutes and fell to negligible levels. It was called the first selective growth hormone secretagogue because, in pigs, it did not raise ACTH or cortisol the way older peptides did. It contains no growth hormone and is not a steroid. See what is ipamorelin.

  • Side by side

    Tirzepatide Ipamorelin
    Receptor GIP and GLP-1 Ghrelin receptor, GHS-R1a
    What the natural signal does Fullness after eating Hunger, and a growth hormone pulse
    Gastric emptying Slowed Faster in rat studies
    Glucose direction Improves insulin signalling Growth hormone raises blood glucose
    Human evidence Large randomised trials of the approved product One intravenous volunteer study and one negative surgical trial; no data for the subcutaneous route
    Schedule at Pepti Once weekly Monday through Friday nights at bedtime

Can You Take Ipamorelin With Tirzepatide or Semaglutide?

Why it is paired at all

In the STEP 1 body-composition substudy of semaglutide, both fat mass and lean mass fell, though fat fell by more. Losing muscle alongside fat leaves people weaker with a lower resting metabolic rate, and strong appetite suppression makes under-eating protein the default. That is the rationale prescribers give for adding a growth-hormone-axis peptide: lean tissue, alongside resistance training and a protein target, not instead of them.

What the pairing does not have is evidence that it works. No trial shows a growth hormone secretagogue preserves lean mass during GLP-1 treatment, and there are no human data on ipamorelin and body composition at all. A protein target and resistance training two to three times a week remain the countermeasures with the most behind them. More is in what peptides can you take with tirzepatide.

Can You Take Ipamorelin With Tirzepatide or Semaglutide?

The three opposing effects

  • 1. Appetite

    Ipamorelin acts at the receptor ghrelin uses to signal hunger, and hunger after the injection is one of the effects prescribers report. In a 2001 mouse study, twice-daily ipamorelin increased body weight, fat-pad weight and food intake. That does not mean it will make a person gain weight; there are no human data either way. It does mean the animal evidence does not support fat loss as an effect, and that some people on a GLP-1 notice their appetite returning in the evening. Bedtime dosing means the pulse lands while you are going to sleep, but tell your care team if appetite changes.

  • 2. Gastric emptying

    Ghrelin receptors also sit on the nerves that drive stomach and intestinal movement. In rats, ipamorelin shortened time to first bowel movement after abdominal surgery and sped gastric emptying. Tirzepatide does the opposite, which is the source of most of its stomach side effects. Nobody has studied what the two do together. In the one randomised human trial, of intravenous ipamorelin after bowel surgery, it did not separate from placebo, so the rat effect has not been shown in people.

  • 3. Glucose

    Growth hormone reduces insulin sensitivity; GLP-1 medications act in the other direction. Anything that raises growth hormone can raise blood glucose, which is why diabetes and impaired glucose tolerance are raised at intake for ipamorelin. Prescribing a growth-hormone-axis peptide with a GLP-1 is routine and legitimate, and it is a good example of why the monitoring plan is part of the prescription. If you take insulin or a sulfonylurea, low blood glucose on tirzepatide becomes more likely, and that needs to be on your intake too.

Can You Take Ipamorelin With Tirzepatide or Semaglutide?

Symptoms that could come from either

Symptom On tirzepatide On ipamorelin
Hunger Reduced appetite is expected Hunger after the injection is reported
Light-headedness or dizziness 4 to 5% on the approved weight-management label, against 2% Reported after injection
Headache Not in the label figures on the tirzepatide side effects page Reported after injection
Flushing or warmth Not in the label figures Reported after injection
Nausea, reflux, constipation The most common effects, around starting and dose increases Not described
Injection-site redness 6 to 8% on the label Reported
Fluid retention Not in the label figures A growth hormone class risk

Start ipamorelin when your GLP-1 dose is steady, not in the week of an increase, so a change has one plausible cause.

Can You Take Ipamorelin With Tirzepatide or Semaglutide?

Fitting the schedules together

Ipamorelin Tirzepatide
Draw 0.25 mL (25 units on a U-100 insulin syringe) 0.50 mL (50 units)
Medication per dose 0.25 mg ipamorelin Your weekly strength, 2.5 mg to 15 mg
How often Monday through Friday nights at bedtime Once weekly, same day each week
Doses per vial 20 4
One vial lasts About four weeks Four weeks

The ipamorelin figures are math from the vial: 0.25 mL of a 1 mg/mL solution is 0.25 mg, and 5 mL at 0.25 mL is 20 doses, five nights a week for four weeks. Both run on a 28-day refill cycle, one vial per fill.

  • Two vials, two syringes, two sites. Never mix them in one syringe.
  • Bedtime is part of the schedule. It lands the pulse on the natural nocturnal release rather than after a meal, which is described as blunting the response.
  • Keep your tirzepatide day fixed, and use a different site on a shared day.

Ipamorelin inside a combination

Ipamorelin is also in CJC-1295 / Ipamorelin ($239 a month), Ipamorelin + Sermorelin ($219), Tesamorelin + Ipamorelin ($259), and blends including PHYSIQ and SHRED, which are commonly used alongside a GLP-1. These add a GHRH-receptor signal, which is additive at the pituitary. If you take any of them, a separate ipamorelin vial would duplicate it. See what is CJC-1295 / Ipamorelin.

Can You Take Ipamorelin With Tirzepatide or Semaglutide?

Who should discuss it first

Situation Why
Diabetes or impaired glucose tolerance Growth hormone can raise blood glucose
Insulin or a sulfonylurea Low blood glucose on tirzepatide becomes more likely
Personal history of cancer A theoretical growth hormone class concern about existing tumours
Personal or family history of medullary thyroid carcinoma or MEN 2 Rules out tirzepatide and semaglutide
Pregnancy, planning pregnancy or breastfeeding Neither is used
Already on a blend containing ipamorelin Duplication
Oral contraceptives May be absorbed less reliably for four weeks after starting tirzepatide and after each dose increase
Tested athlete Many peptides are prohibited in competition; check your sport's list

Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.

Can You Take Ipamorelin With Tirzepatide or Semaglutide?

Semaglutide works the same way

Semaglutide acts at GLP-1 only, where tirzepatide acts at GLP-1 and GIP, but it reduces appetite and slows gastric emptying in the same way, so the same three opposing effects apply. Semaglutide and tirzepatide are never taken together; see semaglutide vs tirzepatide.

Can You Take Ipamorelin With Tirzepatide or Semaglutide?

How to add ipamorelin to a GLP-1 properly

  1. Name the gap. "I am worried about losing muscle" gives your physician more to work with than a molecule name.
  2. Keep the basics in place. A protein target and resistance training are the countermeasures with the most behind them.
  3. List glucose-related history and medications in full.
  4. Start when your GLP-1 dose is steady, and report appetite changes.

Your physician sets your directions after reviewing your intake, and every vial arrives with its directions printed on the label. More is in can you take two peptides together. Step-by-step: how to get ipamorelin prescribed and how to get tirzepatide prescribed.

Can You Take Ipamorelin With Tirzepatide or Semaglutide?

What the evidence shows, honestly

Tirzepatide has a large human trial base in its approved form. Ipamorelin's human evidence is one intravenous volunteer study confirming growth hormone release and one randomised surgical trial that did not meet its endpoints; there are no human data for the subcutaneous route and none on body composition. On regulation, the FDA removed it from Category 2 in September 2024, and in October 2024 the advisory committee voted 0 to 12, with one abstention, against adding it to the 503A Bulks List for the two uses it examined; no final determination has been issued. There is no study of ipamorelin with any GLP-1. The pairing is grounded in mechanism and prescriber experience, which is a reasonable basis for prescribing and not evidence that the combination does better than tirzepatide alone.

References

What this is based on.

References

  1. Wilding JPH, Batterham RL, Calanna S, et al.. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) · New England Journal of Medicine (2021) · PMID 33567185
  2. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al.. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT) · New England Journal of Medicine (2023) · PMID 37952131
  3. Wadden TA, Bailey TS, Billings LK, et al.. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity (STEP 3) · JAMA (2021) · PMID 33625476
  4. Rubino D, Abrahamsson N, Davies M, et al.. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial · JAMA (2021) · PMID 33755728
  5. Marso SP, Bain SC, Consoli A, et al.. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6) · New England Journal of Medicine (2016) · PMID 27633186
  6. Davies M, Færch L, Jeppesen OK, et al.. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial · The Lancet (2021) · PMID 33667417
  7. Garvey WT, Batterham RL, Bhatta M, et al.. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial · Nature Medicine (2022) · PMID 36216945
  8. Rubino DM, Greenway FL, Khalid U, et al.. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial · JAMA (2022) · PMID 35015037
  9. Aronne LJ, Horn DB, le Roux CW, et al.. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5) · New England Journal of Medicine (2025) · PMID 40353578
  10. Sanyal AJ, Newsome PN, Kliers I, et al.. Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis (ESSENCE) · New England Journal of Medicine (2025) · PMID 40305708
  11. Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K et al.. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension · Diabetes Obes Metab (2022) · PMID 35441470
  12. Batsis JA, Gavras A, Gross DC, Cheever CR, Da Silva BR et al.. Effect of Incretin-Based and Nonpharmacologic Weight Loss on Body Composition: A Systematic Review · Ann Intern Med (2026) · PMID 41996180

Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.

Common questions

Can You Take Ipamorelin With Tirzepatide or Semaglutide?, answered.

It can be prescribed alongside tirzepatide when a physician reviewing your intake judges it appropriate, usually with lean tissue in mind. No study has tested the combination.

Next step

See what a physician recommends for you.

A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.